Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs

Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs

The purpose of this population-based case&#8722;control study was to clarify the impact of cumulative dosage of nonsteroidal anti-inflammatory drugs (NSAIDs) on recurrent peptic ulcers among chronic users after <i>Helicobacter pylori (H. pylori)</i> eradication. We analyzed data of 2...

Full description

Bibliographic Details
Main Authors: Chih-Ming Liang, Shih-Cheng Yang, Cheng-Kun Wu, Yu-Chi Li, Wen-Shuo Yeh, Wei-Chen Tai, Chen-Hsiang Lee, Yao-Hsu Yang, Tzu-Hsien Tsai, Chien-Ning Hsu, Seng-Kee Chuah
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Clinical Medicine
Subjects:
nationwide study
nonsteroidal anti-inflammatory drugs
<i>helicobacter pylori</i> eradication therapy
recurrent peptic ulcer disease
Online Access:https://www.mdpi.com/2077-0383/8/10/1722

Internet

https://www.mdpi.com/2077-0383/8/10/1722

Similar Items